Influencing factors of radioiodine therapy in hyperthyroidism in adults
- 1. Department of Nuclear Medicine, No.3 Hospital Affiliated to Sun Yat-sen Univ., Guangzhou (China)
- 2. Department of Infection Disease, No.3 Hospital Affiliated to Sun Yat-sen Univ., Guangzhou (China)
- 3. Department of Radiology No.3 Hospital Affiliated to Sun Yat-sen Univ., Guangzhou (China)
Description
The study was to evaluate factors affecting outcome of 131I therapy in hyperthyroidism for optimizing the method. Data from 213 patients who received 131I treatment from July 2003 to July 2005 in our department were retrospectively analyzed. Factors possibly contributing to the outcome of the 1311 therapy were analyzed, including gender, age, history of antithyroid drag, thyroid volume, duration of disease and radioactive iodine uptake rate. Multivariate analysis was done. The rates of euthyroidism and hypothyroidism were 69% and 8.5%, respectively, after one time 131I therapy. Multivariate analysis of the patients showed no statistically significant factors affecting the outcome of 131I therapy. The study showed that 131I dose can be directly calculated, and this simplifies the dose-determined method and individualizes the therapy. (authors)
Additional details
Publishing Information
- Journal Title
- Nuclear Science and Techniques
- Journal Volume
- 18
- Journal Issue
- 5
- Journal Page Range
- p. 294-297
- ISSN
- 1001-8042
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 39070347
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANTITHYROID DRUGS; DOSES; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE 131; PATIENTS; RADIOTHERAPY
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; ENDOCRINE DISEASES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; RADIOISOTOPES; RADIOLOGY; THERAPY
Optional Information
- Notes
- 1 tab., 18 refs.